130 related articles for article (PubMed ID: 23157253)
21. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
Kuroda A; Yasuda T; Takahara M; Sakamoto F; Kasami R; Miyashita K; Yoshida S; Kondo E; Aihara K; Endo I; Matsuoka TA; Kaneto H; Matsumoto T; Shimomura I; Matsuhisa M
Diabetes Technol Ther; 2012 Nov; 14(11):1077-80. PubMed ID: 23101953
[TBL] [Abstract][Full Text] [Related]
23. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
Holcombe JH; Zalani S; Arora VK; Mast CJ;
Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
[TBL] [Abstract][Full Text] [Related]
24. Impact of insulin reduction on glycemic control in children attending a residential diabetes camp.
Lo HL; Adhikari S; White PC; Grishman EK; Gupta OT
Pediatr Diabetes; 2019 Dec; 20(8):1094-1099. PubMed ID: 31456281
[TBL] [Abstract][Full Text] [Related]
25. Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with type 1 diabetes mellitus.
Patton SR; Clements MA; Fridlington A; Cohoon C; Turpin AL; Delurgio SA
Diabetes Technol Ther; 2013 Feb; 15(2):124-8. PubMed ID: 23317372
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST
Hirsch IB; Franek E; Mersebach H; Bardtrum L; Hermansen K
Diabet Med; 2017 Feb; 34(2):167-173. PubMed ID: 26773446
[TBL] [Abstract][Full Text] [Related]
27. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
Sargin H; Sargin M; Altuntaş Y; Sengül AM; Orbay E; Seber S; Uçak S; Yayla A
Diabetes Res Clin Pract; 2003 Nov; 62(2):79-86. PubMed ID: 14581144
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination.
Guillausseau PJ
Diabet Med; 1997 Sep; 14(9):798-802. PubMed ID: 9300232
[TBL] [Abstract][Full Text] [Related]
29. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study.
Tamás G; Marre M; Astorga R; Dedov I; Jacobsen J; Lindholm A;
Diabetes Res Clin Pract; 2001 Nov; 54(2):105-14. PubMed ID: 11640994
[TBL] [Abstract][Full Text] [Related]
30. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
31. Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus.
Ford-Adams ME; Murphy NP; Moore EJ; Edge JA; Ong KL; Watts AP; Acerini CL; Dunger DB
Diabet Med; 2003 Aug; 20(8):656-60. PubMed ID: 12873294
[TBL] [Abstract][Full Text] [Related]
32. Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes.
Roach P; Strack T; Arora V; Zhao Z
Int J Clin Pract; 2001 Apr; 55(3):177-82. PubMed ID: 11351771
[TBL] [Abstract][Full Text] [Related]
33. Impact of a pioneer diabetes camp experience on glycemic control among children and adolescents living with type 1 diabetes in sub-Saharan Africa.
Dehayem MY; Takogue R; Choukem SP; Donfack OT; Katte JC; Sap S; Sobngwi E; Mbanya JC
BMC Endocr Disord; 2016 Jan; 16():5. PubMed ID: 26791079
[TBL] [Abstract][Full Text] [Related]
34. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
35. Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.
Colombel A; Murat A; Krempf M; Kuchly-Anton B; Charbonnel B
Diabet Med; 1999 Apr; 16(4):319-24. PubMed ID: 10220206
[TBL] [Abstract][Full Text] [Related]
36. Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp.
Nagl K; Berger G; Aberer F; Ziko H; Weimann K; Bozic I; Rami-Merhar B; Mader JK
Pediatr Diabetes; 2021 Mar; 22(2):271-278. PubMed ID: 33219728
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
38. In children and young people with type 1 diabetes using Pump therapy, an additional 40% of the insulin dose for a high-fat, high-protein breakfast improves postprandial glycaemic excursions: A cross-over trial.
Smith TA; Smart CE; Fuery MEJ; Howley PP; Knight BA; Harris M; King BR
Diabet Med; 2021 Jul; 38(7):e14511. PubMed ID: 33405297
[TBL] [Abstract][Full Text] [Related]
39. Insulin during pregnancy, labour and delivery.
de Valk HW; Visser GH
Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
[TBL] [Abstract][Full Text] [Related]
40. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
